患有抑郁症的老年门诊患者中患病率和可能不适当的处方因素:在中国进行的一项多中心研究
Fangyuan Tian1, Zhaoyan Chen1,2, Ying Zhang1
1Department of Pharmacy, National Clinical Research Centre for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
Journal of global health
|July 11, 2025
概括
潜在不合适的处方 (PIP) 影响了中国超过一半的抑郁症老年门诊患者. 诸如医院级别和多药店等因素增加了PIP风险,突出显示了在这个人群中改善药物管理的需要.
科学领域:
- 老年人药房 老年人药房
- 精神病学药房 精神病学药房
- 公共卫生 公共卫生
背景情况:
- 患有抑郁症的老年人面临潜在不适当处方 (PIP) 的高风险.
- 这项研究调查了中国老年患有抑郁症的门诊患者中PIP的患病率和相关因素.
研究的目的:
- 确定中国老年抑郁症门诊患者中PIP的发生频率.
- 在这个人口群体中识别与PIP相关的风险因素.
主要方法:
- 一项横截面研究分析了来自中国七个城市的90家医院的处方数据 (2021年1月至12月).
- 多变量逻辑回归确定了PIP的风险因素.
- 结点回归评估了PIP流行趋势.
主要成果:
- PIP的总体患病率为50.42%.
- 最常见的PIM包括阿尔普拉佐拉姆,克罗纳泽帕姆,奥兰扎平,洛拉泽帕姆和埃斯塔佐拉姆.
- PIP的流行率略有下降 (APC = -0.335%).
- 对PIP的风险因素包括三级医院,精神病学部门,年龄≥80,多种并发症和多药.
结论:
- 在中国,潜在不适当的处方 (PIP) 在患有抑郁症的老年门诊患者中非常普遍.
- 识别和解决风险因素对于改善这种脆弱人群的药物安全至关重要.
相关概念视频
Depressive Disorders: Etiology
173
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
173
Antidepressant Drugs: MAOIs and Other Agents
373
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
373
Antidepressant Drugs: Overview
786
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
786
Depression: Overview
361
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
361
Long-term Depression
31.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.5K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
609
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
609


